• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的胃肠功能障碍

Gastrointestinal Dysfunction in Parkinson's Disease.

作者信息

Pfeiffer Ronald F

机构信息

Department of Neurology, Oregon Health and Science University, Portland, OR, USA.

出版信息

Curr Treat Options Neurol. 2018 Oct 25;20(12):54. doi: 10.1007/s11940-018-0539-9.

DOI:10.1007/s11940-018-0539-9
PMID:30361783
Abstract

PURPOSE OF REVIEW

During the past 25 years, there has been an explosion of information regarding the occurrence of gastrointestinal dysfunction in Parkinson's disease. In this review, the clinical features of gastrointestinal dysfunction in Parkinson's disease will be described and information regarding the potential role of the enteric nervous system and the gut microbiome in the genesis of Parkinson's disease will be addressed.

RECENT FINDINGS

Recognition is growing regarding the role that gastroparesis and small intestinal dysfunction may play in Parkinson's disease, especially with regard to erratic responses to anti-Parkinson medication. The presence of enteric nervous system involvement in Parkinson's disease is now well established, but whether the enteric nervous system is the starting point for Parkinson's disease pathology remains a source of debate. The potential role of the gut microbiome also is beginning to emerge. Gastrointestinal dysfunction is a prominent nonmotor feature of Parkinson's disease and dysfunction can be found along the entire length of the gastrointestinal tract. The enteric nervous system is clearly involved in Parkinson's disease. Whether it is the initial source of pathology is still a source of controversy. There also is growing recognition of the role that the gut microbiome may play in Parkinson's disease, but much more research is needed to fully assess this aspect of the disorder.

摘要

综述目的

在过去25年里,关于帕金森病中胃肠功能障碍发生情况的信息呈爆炸式增长。在本综述中,将描述帕金森病中胃肠功能障碍的临床特征,并探讨肠神经系统和肠道微生物群在帕金森病发病机制中的潜在作用。

最新发现

人们越来越认识到胃轻瘫和小肠功能障碍在帕金森病中可能发挥的作用,特别是在对帕金森病药物的不稳定反应方面。目前已充分证实帕金森病存在肠神经系统受累情况,但肠神经系统是否为帕金森病病理的起始点仍存在争议。肠道微生物群的潜在作用也开始显现。胃肠功能障碍是帕金森病突出的非运动特征,且在胃肠道全长均可发现功能障碍。肠神经系统显然与帕金森病有关。它是否为病理的最初来源仍存在争议。人们也越来越认识到肠道微生物群在帕金森病中可能发挥的作用,但需要更多研究来全面评估该疾病的这一方面。

相似文献

1
Gastrointestinal Dysfunction in Parkinson's Disease.帕金森病中的胃肠功能障碍
Curr Treat Options Neurol. 2018 Oct 25;20(12):54. doi: 10.1007/s11940-018-0539-9.
2
Gut dysfunction in Parkinson's disease.帕金森病中的肠道功能障碍。
World J Gastroenterol. 2016 Jul 7;22(25):5742-52. doi: 10.3748/wjg.v22.i25.5742.
3
Implications of the Gut Microbiome in Parkinson's Disease.肠道微生物组在帕金森病中的意义。
Mov Disord. 2020 Jun;35(6):921-933. doi: 10.1002/mds.28004. Epub 2020 Feb 24.
4
The Gut and Nonmotor Symptoms in Parkinson's Disease.帕金森病中的肠道与非运动症状
Int Rev Neurobiol. 2017;134:787-809. doi: 10.1016/bs.irn.2017.05.027. Epub 2017 Jul 3.
5
Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.帕金森病中肠道微生物群的改变与肠道病理
J Mov Disord. 2019 May;12(2):67-83. doi: 10.14802/jmd.18067. Epub 2019 May 30.
6
A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson's Disease.帕金森病中肠神经元缺失与便秘的批判性分析。
J Parkinsons Dis. 2022;12(6):1841-1861. doi: 10.3233/JPD-223262.
7
Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson's disease.肠道微生物群-脑轴:帕金森病中迷走神经、α-突触核蛋白与大脑之间的相互作用
Neural Regen Res. 2023 Dec;18(12):2611-2614. doi: 10.4103/1673-5374.373673.
8
Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.帕金森病与糖尿病:对病理生理学和胃肠动力的协同作用
Curr Gastroenterol Rep. 2023 May;25(5):106-113. doi: 10.1007/s11894-023-00868-7. Epub 2023 Apr 17.
9
The gut in Parkinson's disease: Bottom-up, top-down, or neither?帕金森病中的肠道:由下而上,由上而下,还是都不是?
Neurogastroenterol Motil. 2020 Jan;32(1):e13777. doi: 10.1111/nmo.13777.
10
Constipation in Parkinson's Disease.帕金森病中的便秘
Int Rev Neurobiol. 2017;134:811-826. doi: 10.1016/bs.irn.2017.06.003. Epub 2017 Jul 13.

引用本文的文献

1
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations.持续皮下注射左旋多巴/卡比多巴乙酯的真实世界经验:见解与建议。
J Neural Transm (Vienna). 2025 Mar 22. doi: 10.1007/s00702-025-02911-5.
2
Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson's disease models via PMK-1/p38 MAPK and SKN-1/Nrf2 signaling.生物膜形成能力强的枯草芽孢杆菌通过PMK-1/p38丝裂原活化蛋白激酶和SKN-1/Nrf2信号通路预防秀丽隐杆线虫帕金森病模型中的神经退行性变。
Sci Rep. 2025 Mar 21;15(1):9864. doi: 10.1038/s41598-025-93737-4.
3
Overall and Regional Colonic Transit Abnormalities in Elderly Patients with Constipation.

本文引用的文献

1
Wisconsin's Enterra Therapy Experience: A multi-institutional review of gastric electrical stimulation for medically refractory gastroparesis.威斯康星州的 Enterra 治疗体验:胃电刺激治疗药物难治性胃轻瘫的多机构回顾。
Surgery. 2018 Oct;164(4):760-765. doi: 10.1016/j.surg.2018.04.043. Epub 2018 Jul 30.
2
A Critical Review of the Current Clinical Landscape of Gastroparesis.胃轻瘫当前临床状况的批判性综述
Gastroenterol Hepatol (N Y). 2018 Mar;14(3):140-145.
3
Dysphagia Causes Symptom Fluctuations after Oral L-DOPA Treatment in a Patient with Parkinson Disease.
老年便秘患者的全结肠及节段性结肠传输异常
Dig Dis Sci. 2025 Mar;70(3):1132-1141. doi: 10.1007/s10620-024-08833-8. Epub 2025 Jan 8.
4
Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota.帕金森病与微生物群-肠-脑轴:代谢物、机制及针对肠道微生物群的创新治疗策略
Mol Neurobiol. 2025 Apr;62(4):5273-5296. doi: 10.1007/s12035-024-04584-9. Epub 2024 Nov 12.
5
Novel strategies in Parkinson's disease treatment: a review.帕金森病治疗的新策略:综述
Front Mol Neurosci. 2024 Aug 9;17:1431079. doi: 10.3389/fnmol.2024.1431079. eCollection 2024.
6
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.在一大群晚期帕金森病患者中,从开始就使用 24 小时左旋多巴卡比多巴肠凝胶。
Sci Rep. 2024 Feb 14;14(1):3676. doi: 10.1038/s41598-024-54299-z.
7
Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy.帕金森病、便秘、微生物与微生物疗法之间的关系。
World J Gastroenterol. 2024 Jan 21;30(3):225-237. doi: 10.3748/wjg.v30.i3.225.
8
Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota.间歇性禁食与神经疾病:肠道微生物群的潜在作用。
Nutrients. 2023 Nov 24;15(23):4915. doi: 10.3390/nu15234915.
9
Neuroimmune Connectomes in the Gut and Their Implications in Parkinson's Disease.肠道中的神经免疫连接组及其在帕金森病中的意义。
Mol Neurobiol. 2024 Apr;61(4):2081-2098. doi: 10.1007/s12035-023-03679-z. Epub 2023 Oct 16.
10
Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson's disease.肠道微生物群-脑轴:帕金森病中迷走神经、α-突触核蛋白与大脑之间的相互作用
Neural Regen Res. 2023 Dec;18(12):2611-2614. doi: 10.4103/1673-5374.373673.
帕金森病患者口服左旋多巴治疗后吞咽困难导致症状波动
Case Rep Neurol. 2018 Mar 28;10(1):101-107. doi: 10.1159/000488138. eCollection 2018 Jan-Apr.
4
A wrinkle in ON-time - A GI structural abnormality confounding levodopa therapy with Duodopa rescue; a case study.准时出现的波折——一种混淆左旋多巴治疗与多多巴救援的胃肠道结构异常;病例报告
Parkinsonism Relat Disord. 2018 May;50:130-131. doi: 10.1016/j.parkreldis.2018.02.021. Epub 2018 Feb 10.
5
Parkinson's disease from the gut.源自肠道的帕金森病。
Brain Res. 2018 Aug 15;1693(Pt B):201-206. doi: 10.1016/j.brainres.2018.01.010. Epub 2018 Jan 31.
6
Vertebrate food products as a potential source of prion-like α-synuclein.脊椎动物食品作为朊病毒样α-突触核蛋白的潜在来源。
NPJ Parkinsons Dis. 2017 Nov 24;3:33. doi: 10.1038/s41531-017-0035-z. eCollection 2017.
7
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.微生物群-脑-肠轴与神经退行性疾病。
Curr Neurol Neurosci Rep. 2017 Oct 17;17(12):94. doi: 10.1007/s11910-017-0802-6.
8
Does Parkinson's disease start in the gut?帕金森病始于肠道吗?
Acta Neuropathol. 2018 Jan;135(1):1-12. doi: 10.1007/s00401-017-1777-8. Epub 2017 Oct 16.
9
Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.将胃闪烁扫描与症状与动力胶囊通过时间和胃轻瘫压力检测结果相关联。
Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13196. Epub 2017 Sep 5.
10
Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease.帕金森病内镜下肉毒毒素注射的初步队列研究。
Parkinsonism Relat Disord. 2017 Nov;44:33-37. doi: 10.1016/j.parkreldis.2017.08.020. Epub 2017 Aug 23.